The Brutalist Report

Quartz

• Chief CEO Alison Moore says this is a moment for AI leadership at HumanX [17d]
• Haas F1 team principal Ayao Komatsu on expectations ahead of Miami grand prix [17d]
• 600 Google employees are urging CEO Sundar Pichai to block classified Pentagon AI deals [17d]
• SiriusXM and iHeartMedia might merge as radio struggles to survive [17d]
• Quasar Markets CEO Steve Orr delivers takeaways from earnings season thus far [17d]
• Shell Foundation CEO Jonathan Berman talks blended finance at Semafor Summit [17d]
• Accenture is rolling out Microsoft's AI assistant to 100,000 workers, with plans to double that [17d]
• Disney is reorganizing its streaming data and product teams as new CEO cuts 1,000 jobs [17d]
• Marvell cancels POET Technologies orders after confidentiality breach, stock falls 46% [17d]
• Maryland is set to become the first state to ban dynamic pricing at grocery stores [17d]
• Tech guru Angelo Zino sets scene as tech heavyweights report earnings this week [17d]
• Tech guru Angelo Zino sets scene as tech heavyweights report earnings this week [17d]
• Budget airlines are asking the U.S. government for $2.5 billion in fuel-cost relief [17d]
• NYSE's Eric Criscuolo previews action-packed week as S&P 500 hits fresh record [17d]
• Team8 co-founder Liran Grinberg on 'building new companies from scratch' at RSA [17d]
• American Airlines is raising $1.14 billion in aircraft-backed bonds to fund new planes [17d]
• Veradermics says its hair loss pill passed a late-stage trial, potentially the first oral treatment approved in 30 years [17d]
• Paramount is asking the FCC to approve its Gulf and Chinese investors for the Warner Bros. deal [17d]
• EssilorLuxottica heir wins approval to buy out 2 siblings in €10 billion deal [17d]
• Ex-DeepMind researcher raises $1.1B seed round for London AI startup Ineffable Intelligence [17d]
• Bill Ackman's Pershing Square IPO is expected to raise $5 billion [17d]
• Intellia is seeking FDA approval for what could be the first in vivo CRISPR gene editing therapy [17d]
• The Container Store is gutting 30% of inventory across 98 stores to make room for Bed Bath & Beyond [17d]
• Samsung Wallet is adding a trip-planning tool to organize all your travel in one place [17d]
• Spotify is launching a fitness hub with more than 1,400 Peloton workout classes [17d]
• An investment banker is trying to swap his Bay Area estate for Anthropic shares [17d]
• Thermo Fisher is selling its microbiology unit to Astorg for $1.08 billion [17d]
• Oruka Therapeutics drug cleared skin in 64% of psoriasis patients in trial [17d]
• Supreme Court heard arguments in Bayer's Roundup cancer case that could gut 100,000 lawsuits [17d]
• Customers Bank is embedding OpenAI engineers to automate commercial lending [17d]
• Oprah Winfrey is bringing her podcast and TV archive to Amazon in a multiyear deal [17d]
• Real Brokerage is acquiring RE/MAX in an $880 million real estate mega-merger [17d]
• Satellite intelligence firm HawkEye 360 is seeking a $2.4 billion valuation in its U.S. IPO [17d]
• OpenAI and Microsoft are renegotiating how much revenue the AI startup owes its backer [17d]
• Taiwan sentenced a former Tokyo Electron engineer to 10 years for stealing TSMC chip secrets [17d]
• Ligand Pharmaceuticals is buying rival biotech royalty firm XOMA for $739 million [17d]
• Related Digital and Blackstone secure $16 billion to build Oracle's Michigan AI data center [17d]
• Google is building its first AI campus outside the U.K. in Seoul, South Korea [17d]
• OpenAI is reportedly building an AI smartphone with Qualcomm and MediaTek chips [17d]
• Elon Musk and Sam Altman are heading to trial over OpenAI's for-profit shift [17d]
• United Airlines CEO confirms he pitched American Airlines on a merger that went nowhere [17d]
• Shell is buying Canadian oil and gas producer ARC Resources in a $16.4 billion deal [17d]
• A key Republican senator dropped his blockade of Trump's Fed chair nominee [17d]
• Meta is betting on solar energy beamed from space to power its AI data centers [17d]
• Sun Pharmaceutical is buying Organon in an $11.75 billion all-cash deal [17d]
• Eli Lilly is acquiring blood cancer drug developer Ajax Therapeutics for up to $2.3 billion [17d]
• Domino's Pizza missed sales and earnings expectations as cautious consumers held back [17d]